- Home
- FSTR vs ITOS Comparison
FSTR vs ITOS Comparison
Compare FSTR & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- ITOS
- Stock Information
- Founded
- FSTR 1902
- ITOS 2011
- Country
- FSTR United States
- ITOS United States
- Employees
- FSTR N/A
- ITOS N/A
- Industry
- FSTR Metal Fabrications
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSTR Industrials
- ITOS Health Care
- Exchange
- FSTR Nasdaq
- ITOS Nasdaq
- Market Cap
- FSTR 304.1M
- ITOS 283.9M
- IPO Year
- FSTR N/A
- ITOS 2020
- Fundamental
- Price
- FSTR $28.47
- ITOS $7.52
- Analyst Decision
- FSTR Hold
- ITOS Strong Buy
- Analyst Count
- FSTR 1
- ITOS 3
- Target Price
- FSTR $25.00
- ITOS $25.33
- AVG Volume (30 Days)
- FSTR 40.4K
- ITOS 448.3K
- Earning Date
- FSTR 11-07-2024
- ITOS 11-12-2024
- Dividend Yield
- FSTR N/A
- ITOS N/A
- EPS Growth
- FSTR N/A
- ITOS N/A
- EPS
- FSTR 3.85
- ITOS N/A
- Revenue
- FSTR $537,459,000.00
- ITOS $35,000,000.00
- Revenue This Year
- FSTR $0.44
- ITOS $271.18
- Revenue Next Year
- FSTR $7.16
- ITOS N/A
- P/E Ratio
- FSTR $7.42
- ITOS N/A
- Revenue Growth
- FSTR N/A
- ITOS N/A
- 52 Week Low
- FSTR $14.23
- ITOS $7.44
- 52 Week High
- FSTR $30.77
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- FSTR 64.66
- ITOS 34.10
- Support Level
- FSTR $27.86
- ITOS $7.44
- Resistance Level
- FSTR $29.40
- ITOS $7.96
- Average True Range (ATR)
- FSTR 0.98
- ITOS 0.34
- MACD
- FSTR -0.31
- ITOS -0.02
- Stochastic Oscillator
- FSTR 40.29
- ITOS 9.97
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through three segments: Rail Technologies and Services; Precast Concrete Products and Steel Products and Measurement. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.